Using Controlled Substances for Pediatric Behavioral Health
1.25 NAPNAP Contact Hour, including 1.25 Pharmacology hours, 1.25 Psychopharmacology hours and 1.25 Controlled substance hours. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference.
The purpose of this presentation is to provide the pediatric-focused APRN with a review of the psychopharmacologic controlled substance agents commonly used in pediatric behavioral health. For the novice to experienced provider, this presentation will include information to aid in the evaluation of the effectiveness of these agents and identifying warning signs of significant side effects from their use.
This archived presentation from our 2024 national conference is available as part of a bundle of courses recorded during our 2024 conference in Denver, CO. Purchase the conference bundle to be enrolled in the full library of 2024 conference sessions, and earn up to 27 NAPNAP Contact Hours, 5.5 Pharmacology,1.25 Psychopharmacology and 2.5 Controlled Substance.
This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $60. Non-members may purchase this bundle for $500. Great news - You can join NAPNAP before purchasing to save more than $300. To see the complete listing of courses included in the 2024 conference bundle, click here.
Please note that this program is a recording from a live session from NAPNAP 2024 national conference in Denver, CO. If you earned CE for this session, this course will be a duplicate.
IMPORTANT: You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org
Copyright 2024 © by National Association of Pediatric Nurse Practitioners
Target Audience
Pediatric-focused advanced practice registered nurses.
Learning Objectives
- Apply the current evidence for the use of controlled psychopharmacotherapeutic agents in pediatric behavioral healthcare.
- Discuss the clinical implications for the use of controlled psychopharmacotherapeutic agents in pediatric behavioral healthcare.
- Incorporate knowledge of monitoring parameters required when using controlled pharmacotherapeutic agents in pediatric behavioral healthcare.
Dawn Garzon PhD, CPNP-PC, PMHS, FAANP
Washington University Division of Child & Adolescent Psychiatry St. Louis, MO
Available Credit
- 1.25 Contact hours